Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HBB | P68871 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | DHFR | P00374 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.30 |
| ▸ | CASP7 | P55210 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10329459 | 0.98 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL24855261 | 0.98 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL20495995 | 0.98 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL20495997 | 0.98 | TP53 (0.50) | TP53HBBSMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL17153973 | 0.94 | TP53 (0.47) | TP53HBBSMN1; SMN2ALDH1A1 | |
| SCHEMBL21026336 | 0.93 | TP53 (0.54) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL8580238 | 0.93 | TP53 (0.54) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL21991221 | 0.93 | TP53 (0.54) | TP53HBBSMN1; SMN2ALDH1A1DHFR | |
| SCHEMBL12047489 | 0.92 | TP53 (0.45) | TP53HBBSMN1; SMN2ALDH1A1CYP1A2 | |
| SCHEMBL12060390 | 0.92 | TP53 (0.45) | TP53HBBSMN1; SMN2ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111087809-B | Thermosetting resin composition, prepreg, metal foil laminate and printed wiring board using the same | 台燿科技股份有限公司 | 2022-09-13 | — | — | CN | claimed |
| US-10920008-B2 | Thermal-curable resin composition, and pre-preg, metal-clad laminate and printed circuit board manufactured using the same | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2021-02-16 | — | — | US | claimed |
| CN-111087809-A | Thermosetting resin composition, prepreg, metal foil laminate and printed wiring board using the same | 台燿科技股份有限公司 | 2020-05-01 | — | — | CN | claimed |
| US-20200123307-A1 | THERMAL-CURABLE RESIN COMPOSITION, AND PRE-PREG, METAL-CLAD LAMINATE AND PRINTED CIRCUIT BOARD MANUFACTURED USING THE SAME | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2020-04-23 | — | — | US | claimed |
| US-4376120-A | Therapeutic compositions with a cytostatic action containing isocyanuric acid derivatives and process of manufacture | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1983-03-08 | — | — | US | claimed |
| US-20240413397-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2024-12-12 | — | — | US | disclosed |
| CN-119108629-A | Electrolyte for rechargeable lithium battery and rechargeable battery including the same | 三星SDI株式会社 | 2024-12-10 | — | — | CN | disclosed |
| CN-118103209-A | Composition for forming release layer, laminate, and method for producing laminate | 日产化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| US-20230357488-A1 | CURABLE RESIN COMPOSITION | CANON KK (JP) | 2023-11-09 | — | — | US | disclosed |
| US-11643544-B2 | Resin composition, and prepreg, metal-clad laminate, and printed circuit board prepared using the same | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2023-05-09 | — | — | US | disclosed |
| WO-2023074812-A1 | EPOXY RESIN COMPOSITION | 日産化学株式会社 | 2023-05-04 | — | — | WO | disclosed |
| CN-111087809-B | Thermosetting resin composition, prepreg, metal foil laminate and printed wiring board using the same | 台燿科技股份有限公司 | 2022-09-13 | — | — | CN | disclosed |
| US-8221965-B2 | Antireflective coating compositions | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2012-07-17 | — | — | US | disclosed |
| US-8221965-B2 | Antireflective coating compositions | AZ ELECTRONIC MATERIALS USA CORP. (US) | 2012-07-17 | — | — | US | disclosed |
| WO-2012067071-A1 | POLYFUNCTIONAL EPOXY COMPOUND | 日産化学工業株式会社 (JP) | 2012-05-24 | — | — | WO | disclosed |
| US-20110319589-A1 | LONG CHAIN ALKYLENE GROUP-CONTAINING EPOXY COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110319589-A1 | LONG CHAIN ALKYLENE GROUP-CONTAINING EPOXY COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20100009293-A1 | Antireflective Coating Compositions | MERCK PATENT GMBH (DE) | 2010-01-14 | — | — | US | disclosed |
| US-20100009293-A1 | Antireflective Coating Compositions | MERCK PATENT GMBH (DE) | 2010-01-14 | — | — | US | disclosed |
| US-4376120-A | Therapeutic compositions with a cytostatic action containing isocyanuric acid derivatives and process of manufacture | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1983-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319589-A1 | LONG CHAIN ALKYLENE GROUP-CONTAINING EPOXY COMPOUND | GPR17, ELOVL5, TAS2R16 | TP53 4361/4885HBB 3488/4885SMN1; SMN2 3600/4885 |
| US-20240413397-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | RER1, CLCN2, SLC9B2 | TP53 1647/4885HBB 3634/4885SMN1; SMN2 1749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.